The NHS Puberty Blocker Study – Necessary evil or medical scandal in the making?

Genspect UK and guest speakers Professor Michael Biggs, Dr Louise Irvine and psychotherapist Susan Evans participated in a lively panel debate about the NHS puberty blocker study. Our expert speakers delved deep into the existing evidence base and explored the practical and ethical implications of the study. ____ CME Objectives By the end of this webinar, you will be able to: 1. Describe the historical context and evolution of puberty blocker use for treating adolescent distress, including the Dutch protocol and subsequent implementation in other countries. 2. List key ethical considerations and challenges in conducting clinical trials of puberty blockers in minors, including issues of informed consent and long-term outcomes. 3. Explain the scientific and methodological requirements for valid clinical trials, including the importance of clear diagnostic criteria, measurable outcomes, and appropriate control groups. 4. Identify the potential physical and psychological risks associated with puberty suppression, including impacts on bone density, cognitive development, and sexual development. 5. Discuss the role of comprehensive psychological assessment and therapeutic approaches for young people experiencing distress about their bodies. 6. Compare different research priorities, including the relative merits of new clinical trials versus analysis of existing outcome data. 7. Evaluate the complex interplay between clinical evidence, political considerations, and healthcare providers' ethical obligations when treating distressed youth. CME/CE (Continuing Medical Education/Continuing Education) Option for Genspect Subscribers https://genspect.substack.com CME Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Michigan State Medical Society (MSMS) through the joint providership of Great Lakes Learning, LLC and Genspect. GLL is accredited by MSMS to provide continuing medical education for physicians. GLL designates this live activity for a maximum of AMA PRA Category 1 Credit(s)TM. Each physician should claim only the credit commensurate with the extent of their participation in the activity. Nurses: The ACCME is approved by the board of nurses as an acceptable provider of continuing education for renewal of license. For all other members of the Healthcare Team: A certificate of attendance will be provided to all other healthcare professionals requesting credits in accordance with state licensing boards, specialty societies, or other professional associations. ____ Please subscribe, comment, like and share! Support our work: https://genspect.org/donate/ Follow us on Social Media: X:   / genspect   Facebook:   / genspect   Instagram:   / genspectinternational   Youtube:    / @genspect   ____ #pubertyblockers #debate #webinar